Hereditary Antithrombin Deficiency (EP Video)
Barry Fry from Grifols discusses treatment options for Hereditary Antithrombin Deficiency (05:51 minutes).
The Future of Blood Management (EP Video)
Jim Suroski from Haemonetics discusses the future of blood management (13:10 minutes).
The Future of Blood Management (EP Video)
Jim Suroski from Haemonetics discusses the future of blood management (13:10 minutes).
The Evaluations of Frequency Distribution Heparin Resistance During Coronary Artery Bypass Graft
The goal of this study was the investigation of heparin resistance (HR) prevalence in our country and relation between HR and post-operative coronary artery bypass graft (CABG) complications.
Anticoagulation Drug Therapy: A Review
This review emphasizes the indication, mechanism of action, adverse effects, and potential reversal strategies for various anticoagulants.
Completely Heparinized Cardiopulmonary Bypass and Reduced Systemic Heparin: Clinical and Hemostatic Effects
When heparinized circuits are used for cardiopulmonary bypass, the amounts of heparin and protamine administered systemically can be reduced.
Heparin-Coated Extracorporeal Circulation in Combination with Low Dose Systemic Heparinization Reduces Early Postoperative Blood Loss in Cardiac Surgery
We investigated the effects of heparin-coated circuits in combination with a reduced systemic heparin dose on early postoperative blood loss (first 12 h), platelet function, and postoperative complications.
Heparinized Cardiopulmonary Bypass Circuits and Low Systemic Anticoagulation: An Analysis of Nearly 6000 Patients Undergoing Coronary Artery Bypass Grafting
Heparin coating of cardiopulmonary bypass circuits reduces the inflammatory response and increases the thromboresistance during extracorporeal circulation. These properties enables a lower systemic heparin dose, which has been shown to reduce the need for blood transfusions.
Restoration of the Coagulation Cascade on CPB: A Case Report
Correction of coagulopathy post CPB can present the surgical team with a number of challenges, including right ventricular volume overload, hemodilution, anemia and excessive cell salvage with further loss of coagulation factors.
Monitoring Incomplete Heparin Reversal and Heparin Rebound After Cardiac Surgery
This study assessed the incidence of incomplete heparin reversal and heparin rebound after cardiac surgery with cardiopulmonary bypass (CPB) and the ability of the activated coagulation time (ACT) and thromboelastography (TEG) to detect these phenomena.
A Novel Method for the Direct Determination of Heparin Concentration During Cardiopulmonary Bypass Surgery
The aim of this prospective study was to test a novel light scattering assay (LiSA) for the direct determination of heparin concentration during cardiopulmonary bypass (CPB) surgery and to compare the heparin concentrations with routinely determined activated clotting time (ACT).
Use of Extracorporeal Membrane Oxygenation in Severe Traumatic Lung Injury with Respiratory Failure
We report our experience with the use of extracorporeal membrane oxygenation (ECMO)in severe traumatic lung injury.